Portal de Periódicos da CAPES

Equilibrative Nucleoside Transporter 3 Deficiency Perturbs Lysosome Function and Macrophage Homeostasis

2011; American Association for the Advancement of Science; Volume: 335; Issue: 6064 Linguagem: Inglês

10.1126/science.1213682

1095-9203

Chia‐Lin Hsu, Wei‐Yu Lin, Dhaya Seshasayee, Yung‐Hsiang Chen, Xiao Ding, Zhonghua Lin, Eric Suto, Zhiyu Huang, Wyne P. Lee, Hyunjoo Park, Min Xu, Mei Sun, Linda Rangell, Jeff L. Lutman, Sheila Ulufatu, Eric Stefanich, Cécile Chalouni, Meredith Sagolla, Lauri Diehl, Paul J. Fielder, Brian Dean, Mercedesz Balázs, Flavius Martin,

Calcium signaling and nucleotide metabolism

Lysosomal storage diseases (LSDs) are a group of heterogeneous disorders caused by defects in lysosomal enzymes or transporters, resulting in accumulation of undegraded macromolecules or metabolites. Macrophage numbers are expanded in several LSDs, leading to histiocytosis of unknown pathophysiology. Here, we found that mice lacking the equilibrative nucleoside transporter 3 (ENT3) developed a spontaneous and progressive macrophage-dominated histiocytosis. In the absence of ENT3, defective apoptotic cell clearance led to lysosomal nucleoside buildup, elevated intralysosomal pH, and altered macrophage function. The macrophage accumulation was partly due to increased macrophage colony-stimulating factor and receptor expression and signaling secondary to the lysosomal defects. These studies suggest a cellular and molecular basis for the development of histiocytosis in several human syndromes associated with ENT3 mutations and potentially other LSDs.